Radiation therapy

Orthopedic Clinics of North America

Volumn 31, Issue 4, 2000, Pages 557-566

  Frassica, Deborah A ^b   Thurman, Sarah ^b   Welsh, James ^b  

^a Johns Hopkins   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

LEXIDRONAM SAMARIUM SM 153; RADIOISOTOPE; STRONTIUM 89;

ARTICLE; BONE MARROW SUPPRESSION; BONE METASTASIS; CANCER PAIN; CANCER RADIOTHERAPY; CLINICAL TRIAL; DOSE RESPONSE; FATIGUE; FEMALE; HUMAN; IONIZING RADIATION; MALE; PALLIATIVE THERAPY; POSTOPERATIVE CARE; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RADIOISOTOPE THERAPY; SKIN IRRITATION;

EID: 0033810093     PISSN: 00305898     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0030-5898(05)70175-9     Document Type: Article

References (33)

1. Radiation therapy in the management of symptomatic bone metastasis: The effect of total dose and histology on pain relief and response duration
2. Radioisotopes in the treatment of bone metastasis
3. Re-analysis of the RTOG study of the palliation of symptomatic osseous metastasis
4. The management of metastatic bone disease in the United Kingdom. The Breast Specialty Group of the British Association of Surgical Oncology
5. A randomized trial of single treatment versus conventional fractionation in the palliative radiotherapy of painful bony metastases
6. Insufficiency fractures of the sacrum
7. Pain relief and quality of life following radiotherapy for bone metastases: A randomised trial of two fractionation schedules
8. A prospective randomised trial of 4 Gy or 8 Gy single doses in the treatment of metastatic bone pain
9. Presenting symptoms in patients referred to a multidisciplinary clinic for bone metastases
10. Targeted radionuclide therapy for bone metastases
11. Painful bone metastases: Efficacy of radiotherapy assessed by the patients: A randomized trial comparing 4 Gy x 6 versus 10 Gy x 2
12. Metastatic disease in long bones: A proposed scoring system for diagnosing impending pathologic fractures
13. Pelvic insufficiency fractures in patients with pelvic irradiation
14. Pelvic insufficiency fractures associated with radiation atrophy: Clinical recognition and diagnostic evaluation
15. Randomized trial of single dose versus fractionated palliative radiotherapy of bone metastases
16. Rapid course radiation therapy versus more standard treatment: A randomized trial for bone metastases
17. Randomized prospective clinical study of small, large and twice a day fraction radiotherapy for painful bone metastases
18. Results of a randomized phase-III trial to evaluate the efficacy of strontium-89 adjuvant to local field external beam irradiation in the management of endocrine resistant metastatic prostate cancer
19. A report of RTOG 8206: A phase III study of whether the addition of single dose hemibody irradiation to the standard fractionated local field irradiation is more effective than local field irradiation alone in the treatment of symptomatic osseous metastases
20. Prospective randomised trial of single and multifraction radiotherapy schedules in the treatment of painful bony metastases
21. A comparison of the palliative effects of strontium-89 and external beam radiotherapy in metastatic prostate cancer
22. Irradiation of bone metastases in breast cancer patients: A randomized study with one year follow up
23. Bone metastasis: Review and critical analysis of random allocation trials of local field treatment
24. 153Sm-ethylene-diaminetetramethylenephosphonate (EDTMP) in the treatment of patients with painful bone metastases
25. Singledose half-body irradiation for palliation of multiple bone metastases from solid tumors
26. Systemic (half-body) radiation therapy: Response and toxicity
27. 153Samarium-EDTMP for palliation of bone pain in patients with hormone-refractory prostate cancer
28. Palliation of pain associated with metastatic bone cancer using Samarium-153 lexidronam: A double-blind placebo-controlled clinical trial
29. The palliation of symptomatic osseous metastases
30. Impact of postoperative radiation therapy and other perioperative factors on outcome after orthopaedic stabilization of impending or pathologic fractures due to metastatic disease
31. A phase II study of treatment of painful multi-focal skeletal metastases with single and repeated dose Samarium-153 ethylenedi-aminetetramethylene phosphonate
32. A phase I study of Samarium-153 ethylenedi-aminetetramethylene phosphonate therapy for disseminated skeletal metastases
33. Palliation in painful bone metastases